vs
Foghorn Therapeutics Inc.（FHTX）与FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是FLEXIBLE SOLUTIONS INTERNATIONAL INC的1.0倍（$9.2M vs $9.1M），FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高（-5.1% vs -234.3%，领先229.2%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -0.5%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -0.6%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
FHTX vs FSI — 直观对比
营收规模更大
FHTX
是对方的1.0倍
$9.1M
营收增速更快
FHTX
高出224.3%
-0.5%
净利率更高
FSI
高出229.2%
-234.3%
两年增速更快
FHTX
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $9.1M |
| 净利润 | $-21.7M | $-460.9K |
| 毛利率 | — | 29.4% |
| 营业利润率 | -258.2% | 11.6% |
| 净利率 | -234.3% | -5.1% |
| 营收同比 | 223.8% | -0.5% |
| 净利润同比 | -11.1% | -167.8% |
| 每股收益（稀释后） | $-0.35 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXFSI
| Q4 25 | $9.2M | $9.1M | ||
| Q3 25 | $8.2M | $10.6M | ||
| Q2 25 | $7.6M | $11.4M | ||
| Q1 25 | $6.0M | $7.5M | ||
| Q4 24 | $2.9M | $9.2M | ||
| Q3 24 | $7.8M | $9.3M | ||
| Q2 24 | $6.9M | $10.5M | ||
| Q1 24 | $5.0M | $9.2M |
净利润FHTXFSI
| Q4 25 | $-21.7M | $-460.9K | ||
| Q3 25 | $-15.8M | $-503.4K | ||
| Q2 25 | $-17.9M | $2.0M | ||
| Q1 25 | $-18.8M | $-277.7K | ||
| Q4 24 | $-19.5M | $679.6K | ||
| Q3 24 | $-19.1M | $611.9K | ||
| Q2 24 | $-23.0M | $1.3M | ||
| Q1 24 | $-25.0M | $457.2K |
毛利率FHTXFSI
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 47.4% | ||
| Q1 25 | — | 26.1% | ||
| Q4 24 | — | 29.2% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 37.4% | ||
| Q1 24 | — | 30.6% |
营业利润率FHTXFSI
| Q4 25 | -258.2% | 11.6% | ||
| Q3 25 | -226.9% | 2.9% | ||
| Q2 25 | -279.2% | 29.0% | ||
| Q1 25 | -385.0% | -0.9% | ||
| Q4 24 | -840.5% | 9.4% | ||
| Q3 24 | -305.5% | 20.5% | ||
| Q2 24 | -386.6% | 18.7% | ||
| Q1 24 | -558.3% | 8.3% |
净利率FHTXFSI
| Q4 25 | -234.3% | -5.1% | ||
| Q3 25 | -194.4% | -4.8% | ||
| Q2 25 | -237.3% | 17.8% | ||
| Q1 25 | -316.4% | -3.7% | ||
| Q4 24 | -682.9% | 7.4% | ||
| Q3 24 | -244.9% | 6.6% | ||
| Q2 24 | -333.6% | 12.3% | ||
| Q1 24 | -495.4% | 5.0% |
每股收益（稀释后）FHTXFSI
| Q4 25 | $-0.35 | $-0.03 | ||
| Q3 25 | $-0.25 | $-0.04 | ||
| Q2 25 | $-0.28 | $0.15 | ||
| Q1 25 | $-0.30 | $-0.02 | ||
| Q4 24 | $-0.23 | $0.05 | ||
| Q3 24 | $-0.31 | $0.05 | ||
| Q2 24 | $-0.45 | $0.10 | ||
| Q1 24 | $-0.59 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | — |
| 总债务越低越好 | — | $4.4M |
| 股东权益账面价值 | $-108.5M | $38.9M |
| 总资产 | $198.1M | $61.8M |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资FHTXFSI
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | — | ||
| Q2 25 | $72.6M | $10.0M | ||
| Q1 25 | $61.0M | $11.0M | ||
| Q4 24 | $55.5M | $10.0M | ||
| Q3 24 | $57.7M | $13.0M | ||
| Q2 24 | $138.9M | $9.2M | ||
| Q1 24 | $79.3M | $8.3M |
总债务FHTXFSI
| Q4 25 | — | $4.4M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $8.0M |
股东权益FHTXFSI
| Q4 25 | $-108.5M | $38.9M | ||
| Q3 25 | $-89.7M | $39.0M | ||
| Q2 25 | $-76.7M | $39.4M | ||
| Q1 25 | $-61.7M | $38.4M | ||
| Q4 24 | $-45.5M | $38.0M | ||
| Q3 24 | $-28.3M | $36.9M | ||
| Q2 24 | $-14.3M | $36.2M | ||
| Q1 24 | $-97.5M | $36.0M |
总资产FHTXFSI
| Q4 25 | $198.1M | $61.8M | ||
| Q3 25 | $205.0M | $58.4M | ||
| Q2 25 | $226.2M | $58.2M | ||
| Q1 25 | $258.7M | $61.7M | ||
| Q4 24 | $284.0M | $60.0M | ||
| Q3 24 | $308.4M | $57.8M | ||
| Q2 24 | $328.6M | $56.3M | ||
| Q1 24 | $255.0M | $57.6M |
负债/权益比FHTXFSI
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-4.0M |
| 自由现金流率自由现金流/营收 | — | -44.3% |
| 资本支出强度资本支出/营收 | 0.0% | 11.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-591.7K |
8季度趋势，按日历期对齐
经营现金流FHTXFSI
| Q4 25 | $-22.3M | $-3.0M | ||
| Q3 25 | $-18.9M | $2.0M | ||
| Q2 25 | $-21.0M | $5.3M | ||
| Q1 25 | $-24.0M | $-544.3K | ||
| Q4 24 | $-24.5M | $-2.2M | ||
| Q3 24 | $-21.0M | $2.5M | ||
| Q2 24 | $-25.5M | $5.9M | ||
| Q1 24 | $-29.3M | $-604.8K |
自由现金流FHTXFSI
| Q4 25 | — | $-4.0M | ||
| Q3 25 | — | $39.4K | ||
| Q2 25 | $-21.0M | $4.3M | ||
| Q1 25 | $-24.0M | $-898.4K | ||
| Q4 24 | $-25.0M | $-4.3M | ||
| Q3 24 | $-21.3M | $1.3M | ||
| Q2 24 | $-25.6M | $4.7M | ||
| Q1 24 | $-29.4M | $-1.1M |
自由现金流率FHTXFSI
| Q4 25 | — | -44.3% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | -278.2% | 37.9% | ||
| Q1 25 | -403.2% | -12.0% | ||
| Q4 24 | -875.3% | -47.0% | ||
| Q3 24 | -273.0% | 13.6% | ||
| Q2 24 | -371.0% | 44.9% | ||
| Q1 24 | -583.1% | -11.7% |
资本支出强度FHTXFSI
| Q4 25 | 0.0% | 11.7% | ||
| Q3 25 | 0.0% | 18.7% | ||
| Q2 25 | 0.3% | 8.6% | ||
| Q1 25 | 0.5% | 4.7% | ||
| Q4 24 | 16.8% | 22.8% | ||
| Q3 24 | 4.0% | 13.0% | ||
| Q2 24 | 0.2% | 11.3% | ||
| Q1 24 | 2.0% | 5.2% |
现金转化率FHTXFSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.27× | ||
| Q3 24 | — | 4.05× | ||
| Q2 24 | — | 4.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
